SILEXON
Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening.
SILEXON
Industry:
Artificial Intelligence Machine Learning
Founded:
2018-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.silexon.tech
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Nginx Microsoft Azure DNS Unsplash Alibaba
Similar Organizations
TUNGEE
Tungee is a professional sales intelligence solution provider.
Current Employees Featured
Founder
Investors List
MSA Capital
MSA Capital investment in Series A - Silexon
Shengding Equity Investment Fund
Shengding Equity Investment Fund investment in Series A - Silexon
Prosperico Ventures
Prosperico Ventures investment in Series A - Silexon
Official Site Inspections
http://www.silexon.tech
- Host name: 8.218.208.240
- IP address: 8.218.208.240
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
More informations about "Silexon"
Silexon 2025 Company Profile: Valuation, Funding
Silexon General Information Description. Developer of AI-empowered drug discovery technology for pharmaceutical companies. The company specializes in AI technologies including drug repositioning platforms, macro-molecular โฆSee details»
Silexon AI - LinkedIn
Silexon is an emerging Al-empowered drug discovery company which aims to create an open Al platform for strategic collaboration. Silexon AI/ML platform can facilitate data-driven life science ...See details»
Silexon - VentureRadar
" Silexon is an emerging AI-empowered technology company which aims to create an open AI platform for strategic collaboration in order to facilitate data-driven life science research and โฆSee details»
Silexon - Company Profile - Tracxn
Silexon - Virtual high throughput screening based drug discovery platform. Raised a total funding of $15.5M over 3 rounds from 7 investors. Silexon has 289 competitors. ... Email ID: โฆSee details»
Silexon AI Technology - Company info. interviews, news
Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug โฆSee details»
Silexon - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Silexon . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. About. Silexon is โฆSee details»
Silexon - Funding, Financials, Valuation & Investors - Crunchbase
Oct 17, 2019 Silexon is an AI-based pharmaceutical research and development service provider. ... Resources. Log In. Organization. Silexon . Connect to CRM . Save . Summary. Financials. โฆSee details»
Silexon
Welcome Welcome to Silexon Technology Solutions, the number #1 name in next generation IT Welcome Welcome to Silexon Technology Solutions, the number #1 name in next ...See details»
AI-based Biotech Company Silexon Completes $1.4M โฆ
Nanjing Silexon Intelligent Technology Co., Ltd. ("Silexon") has got tens of millions yuan (US๏ผ1.4 million) in its Pre-A round of financing, led by MSA Capital, with participation from Turing Venture, Prosperico Venture, and โฆSee details»
Silexon - Raised $15.5M Funding from 7 investors - Tracxn
6 days ago Silexon has raised a total funding of $15.5M over 3 rounds from 7 investors. Investors include Sequoia Capital, Eight Roads Ventures and 5 others. Their latest funding โฆSee details»
Silexon - Products, Competitors, Financials, Employees, โฆ
About Silexon. Silexon operates as an artificial intelligence (AI) technology company focusing on biotechnology research and licensing. The company offers services such as search and โฆSee details»
AI-enabled biotech company Silexon closes Series A
Aug 9, 2021 Xin Liu, Partner at Eight Roads, said โSilexon has built a well-balanced team consisting of AI scientists with interdisciplinary capability covering computer science, biology โฆSee details»
Silexon: using AI to disrupt workflows, create assets
Nov 20, 2021 AI company Silexon is applying artificial intelligence and machine-learning research to drug discovery, real-world evidence and customized modeling. The Chinese โฆSee details»
Silexon Partners with Excelra, Deploying GOSTAR to ... - Newswire
Dec 1, 2021 Silexon is an emerging AI-empowered technology company that aims to create an open AI platform for strategic collaboration to facilitate data-driven biopharma research, โฆSee details»
BioDuro & Silexon Form Strategic Collaboration to Develop New โฆ
Dec 3, 2020 SAN DIEGO and SHANGHAI, December 03, 2020 โ BioDuro LLC, a leading global life sciences contract research, development and manufacturing organization (CRDMO), and โฆSee details»
Silexon | VentureRadar
Silexon is an emerging AI-empowered technology company which aims to create an open AI platform for strategic collaboration in order to facilitate data-driven life science research and โฆSee details»
BioDuro & Silexon collaborate on New Anti-Cancer Drugs
Dec 3, 2020 SAN DIEGO & SHANGHAI, December 03, 2020 โ BioDuro LLC, a leading global life sciences contract research, development and manufacturing organization (CRDMO), and โฆSee details»
Silexon - Overview, News & Similar companies | ZoomInfo.com
Silexon. Business Services · China · 30 Employees. Silexon is an emerging AI-empowered technology company that aims to create an open AI platform for strategic collaboration to โฆSee details»
AI in Drug Discovery: Silexon and Excelra Join Forces
Dec 1, 2021 Hyderabad, India and Nanjing, China: December 1, 2021 โ Excelra, a leading global data & analytics provider, today announced its partnership with Silexon AI Technology, โฆSee details»
We Mapped DOGEโs Silicon Valley and Corporate Connections
22 hours ago Hereโs what weโve learned: The DOGE world, as it stands, seems to break down into roughly three categories: former Trump officials, conservative lawyers, and imports from โฆSee details»